Controversies in Hospital Infection Prevention
Wherein we ponder vexing issues in infection prevention and control, inside and outside the hospital.
Controversies in Hospital Infection Prevention's Latest Posts
This NPR interview gives additional information about the unit.
There's an excellent piece in today's New York Times that outlines the dilemma currently faced by hospital epidemiologists across the country: what are the appropriate infection control measures for patients infected with Ebola virus? We've blogged on this issue to some extent before (here and here). Are contact and droplet precautions enough (as recommended by CDC), or do we need Tychem suits, PAPRs, and fluid resistant booties, or maybe even something beyond that?What do we know about […]
Marc Lipsitch (Harvard School of Public Health) and many others are highly concerned about influenza "gain of function" research. Recently, Marc sent around an email that I've posted below as some of you might want to support this effort. Those who would like to learn more about this issue, I suggest you read his recent NYT op-ed, which he mentions below, and also listen to yesterday's NPR Morning Edition discussion on the subject.Dear Colleagues: I want to reach as many colleagues as […]
The planning continues for an exciting SHEA Spring 2015 Conference. The conference will take place May 14-17 in Orlando. The meeting will have a broader format while retaining the highly successful SHEA-CDC Certificate Training Course in Infection Prevention & Healthcare Epidemiology. New additions include a SHEA Certificate Course in Infection Prevention for Long Term Care and focused scientific abstracts related to healthcare epidemiology including poster and oral abstract awards. The […]
We frequently highlight the unintended consequences of antibiotic use, such as C. difficile or adverse drug events, as reasons to discourage inappropriate antibiotic prescribing and advance antibiotic stewardship. Avoidance of unintended consequences is also a major factor in physician selection of antimicrobials. Anecdotally, physicians prefer to avoid clindamycin because it's linked to CDI. In an old study, Jessina McGregor and I found that physicians were approximately twice as likely […]
Log in to leave a comment